Evercore ISI Group Maintains In-Line on Edwards Lifesciences, Lowers Price Target to $76
Portfolio Pulse from Benzinga Newsdesk
Evercore ISI Group analyst Vijay Kumar maintains an In-Line rating on Edwards Lifesciences (NYSE:EW) but lowers the price target from $91 to $76.
July 25, 2024 | 4:41 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Evercore ISI Group analyst Vijay Kumar maintains an In-Line rating on Edwards Lifesciences but lowers the price target from $91 to $76.
The lowered price target from $91 to $76 suggests a less optimistic outlook for Edwards Lifesciences, which could negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100